Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

P. Harnett; M. Buck; P. Beale; A. Goldrick; S. Allan; B. Fitzharris; P. De Souza; M. Links; G. Kalimi; T. Davies; R. Stuart-Harris

doi:10.1111/j.1525-1438.2007.00763.x

Article info

ORIGINAL ARTICLE

Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

Authors

P. Harnett Department of Medical Oncology, Westmead Hospital, Westmead, New South Wales, Australia PubMed articles Google scholar articles
M. Buck Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia PubMed articles Google scholar articles
P. Beale Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articles Google scholar articles
A. Goldrick Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia PubMed articles Google scholar articles
S. Allan Department of Gynecologic Oncology, Palmerston North Hospital, Palmerston North, New Zealand PubMed articles Google scholar articles
B. Fitzharris Department of Medical Oncology, Christchurch Hospital, Christchurch, New Zealand PubMed articles Google scholar articles
P. De Souza Department of Medical Oncology, Cancer Centre, St George Hospital, Kogarah, New South Wales, Australia PubMed articles Google scholar articles
M. Links Department of Medical Oncology, Cancer Centre, St George Hospital, Kogarah, New South Wales, Australia PubMed articles Google scholar articles
G. Kalimi Eli Lilly and Company, Indianapolis, Indiana PubMed articles Google scholar articles
T. Davies Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articles Google scholar articles
R. Stuart-Harris Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articles Google scholar articles

Address correspondence and reprint requests to: Paul Harnett, MB, BS, FRACP, PhD, Westmead Hospital, Cnr Hawkesbury and Darcy Roads, Westmead, NSW 2145, Australia. Email: harnettpr{at}westgate.wh.usyd.edu.au

Citation

Harnett P, Buck M, Beale P, et al

Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study

International Journal of Gynecologic Cancer 2007;17:359-366.

Publication history

First published February 1, 2007.

Online issue publication

March 05, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password